Farner NL - Search Results

1

Distinction between gamma c detection and function in YT lymphoid cells and in the granulocyte-macrophage colony-stimulating factor-responsive human myeloid cell line, Tf-1.

Farner NL, Voss SD, Leary TP, Gan J, Hakimi J, Evans G, Ju G, Sondel PM. Farner NL, et al. Blood. 1995 Dec 15;86(12):4568-78. Blood. 1995. PMID: 8541547 Free article.

2

X-linked severe combined immunodeficiency disease and the gamma c receptor component: prospects for molecular diagnosis.

Farner NL, Voss SD, Sondel PM. Farner NL, et al. Clin Diagn Lab Immunol. 1995 Sep;2(5):518-23. doi: 10.1128/cdli.2.5.518-523.1995. Clin Diagn Lab Immunol. 1995. PMID: 8548528 Free PMC article. Review. No abstract available.

3

Alteration of the CD34+ Tf-1 beta cell line profile in response to long-term exposure to IL-15.

Farner NL, Gan J, de Jong JL, Leary TP, Fenske TS, Buckley P, Dunlap S, Sondel PM. Farner NL, et al. Cytokine. 1997 May;9(5):316-27. doi: 10.1006/cyto.1996.0171. Cytokine. 1997. PMID: 9195130

4

Interaction of IL-15 with the shared IL-2 receptor beta and gamma c subunits. The IL-15/beta/gamma c receptor-ligand complex is less stable than the IL-2/beta/gamma c receptor-ligand complex.

de Jong JL, Farner NL, Widmer MB, Giri JG, Sondel PM. de Jong JL, et al. Among authors: farner nl. J Immunol. 1996 Feb 15;156(4):1339-48. J Immunol. 1996. PMID: 8568232

5

Distinctions in lymphocyte responses to IL-2 and IL-15 reflect differential ligand binding interactions with the IL-2Rbeta chain and suggest differential roles for the IL-2Ralpha and IL-15Ralpha subunits.

de Jong JL, Farner NL, Sondel PM. de Jong JL, et al. Among authors: farner nl. Cytokine. 1998 Dec;10(12):920-30. doi: 10.1006/cyto.1998.0377. Cytokine. 1998. PMID: 10049515

6

Differential quantitative effects of interleukin (IL)-2 and IL-15 on cytotoxic activity and proliferation by lymphocytes from patients receiving in vivo IL-2 therapy.

de Jong JL, Farner NL, Javorsky BR, Lindstrom MJ, Hank JA, Sondel PM. de Jong JL, et al. Among authors: farner nl. Clin Cancer Res. 1998 May;4(5):1287-96. Clin Cancer Res. 1998. PMID: 9607589

7

Ig lambda and heavy chain gene usage in early untreated systemic lupus erythematosus suggests intensive B cell stimulation.

Dörner T, Farner NL, Lipsky PE. Dörner T, et al. Among authors: farner nl. J Immunol. 1999 Jul 15;163(2):1027-36. J Immunol. 1999. PMID: 10395701

8

Molecular mechanisms and selection influence the generation of the human V lambda J lambda repertoire.

Farner NL, Dörner T, Lipsky PE. Farner NL, et al. J Immunol. 1999 Feb 15;162(4):2137-45. J Immunol. 1999. PMID: 9973488

9

Delineation of selective influences shaping the mutated expressed human Ig heavy chain repertoire.

Dörner T, Brezinschek HP, Foster SJ, Brezinschek RI, Farner NL, Lipsky PE. Dörner T, et al. Among authors: farner nl. J Immunol. 1998 Mar 15;160(6):2831-41. J Immunol. 1998. PMID: 9510186

10

Comparable impact of mutational and selective influences in shaping the expressed repertoire of peripheral IgM+/CD5- and IgM+/CD5+ B cells.

Dörner T, Brezinschek HP, Foster SJ, Brezinschek RI, Farner NL, Lipsky PE. Dörner T, et al. Among authors: farner nl. Eur J Immunol. 1998 Feb;28(2):657-68. doi: 10.1002/(SICI)1521-4141(199802)28:02<657::AID-IMMU657>3.0.CO;2-Z. Eur J Immunol. 1998. PMID: 9521076 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters